MedPath

Respiratory Muscle Training in CF Patients

Not Applicable
Completed
Conditions
Cystic Fibrosis
Respiratory Muscles
Registration Number
NCT03190031
Lead Sponsor
University Hospital, Grenoble
Brief Summary

The present study aims at evaluating the effect of respiratory muscle training in adult patients with cystic fibrosis on lung function, exercise performance and quality of life.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
38
Inclusion Criteria
  • Patients with a clinical diagnosis of cystic fibrosis
  • Patients in steady state
Exclusion Criteria
  • Patients during exacerbation
  • Patients treated by oral corticotherapy (>0.5 mg/kg/j during >7 days) during the past 2 months
  • Pregnant patients

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Respiratory muscle enduranceChange from baseline (i.e. T0) measured immediately after the 8 weeks of intervention (T1)

Total breathing duration (in min) measured during an incremental hyperpnea test

Secondary Outcome Measures
NameTimeMethod
Respiratory muscle strengthChange from baseline (i.e. T0) measured immediately after the 8 weeks of intervention (T1)

Peak pressure (in mmHg) during maximal inspiratory and expiratory maneuvers

Maximal cycling performanceChange from baseline (i.e. T0) measured immediately after the 8 weeks of intervention (T1)

Peak maximal power output (in W) during an incremental cycling test

Quality of life of patients after the interventionChange from baseline (i.e. T0) measured immediately after the 8 weeks of intervention (T1)

Score obtained during the questionnaire CQF14+

Trial Locations

Locations (1)

University Hospital

🇫🇷

Grenoble, France

University Hospital
🇫🇷Grenoble, France

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.